A carregar...

Rituximab for Children with Immune Thrombocytopenia: A Systematic Review

BACKGROUND: Rituximab has been widely used off-label as a second line treatment for children with immune thrombocytopenia (ITP). However, its role in the management of pediatric ITP requires clarification. To understand and interpret the available evidence, we conducted a systematic review to assess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liang, Yi, Zhang, Lingli, Gao, Ju, Hu, Die, Ai, Yuan
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3364261/
https://ncbi.nlm.nih.gov/pubmed/22666325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0036698
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!